Skip to main content

Table 2 Clinical profile of study population (n = 81)

From: Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease

Clinical feature

N (%)

Motor symptoms

 Mobility

  Walking without support

68 (84%)

  Walking with support

6 (7.4%)

  Bedridden

7 (8.6%)

 Falls (among those who can walk)

  No falls

46 (56.8%)

  Infrequent falls (< 3/week)

15 (18.5%)

  Frequent falls (≥3/week)

13 (16%)

 Dysarthria

56 (69%)

 Dysphagia

28 (34.6%)

Behavioral/Psychiatric symptom

 Anger outbursts

53 (65.4%)

 Low mood/Depressive symptoms

43 (53%)

 Generalized anxiety

39 (48.1%)

 Apathy

27 (33.3%)

 Delusions (suspiciousness/fear of harm)

32 (39.5%)

 Hallucinatory behavior (self-muttering/laughing)

17 (20.9%)

 Obsessive-compulsive symptoms (repetitive behavior)

17 (20.9%)

 Verbal perseverance

27 (33.3%)

 Addictive behaviour

18 (22.2%)

 Suicidal tendencies

  Attempted

14 (17.2%)

  Ideation only

4 (4.9%)

  Family history of suicide

9 (11.1%)

Cognitive symptoms

37 (45.6%)

Other Symptoms

 Sleep disturbances

37 (45.6%)

 Ongoing weight loss

40 (49.3%)

 Reduced appetite

19 (23.4%)

 Increased appetite

2 (2.5%)

 Bladder incontinence

19 (23.4%)

 Bowel incontinence

9 (11.1%)

 Constipation

15 (18.5%)

 Diabetes mellitus

9/74 (tested)

 Hypothyroidism

12/68 (tested)